City

Manassas (1)

Toronto (1)

Condition

Hypertension (HTN) (2)

Overall Status

Not yet recruiting (1)

Terminated (1)

Sign in for free

Phase

n/a (1)

phase 3 (1)

Sponsor

NYU Langone Health (1)

Quantum Genomics SA (1)

Collaborator

National Heart, Lung, and Blood Institute (NHLBI) (1)

PRA Health Sciences (1)

Intervention

firibastat (qgc001) period 1 (1)

practice facilitation (pf) (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

hypertension (htn)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hypertension (HTN) Trial in Manassas, Toronto (Firibastat (QGC001) Period 1)

Terminated

Hypertension (HTN)

Firibastat (QGC001) Period 1

Manassas, Virginia
+1 more

Jan 13, 2023

Hypertension (HTN) Trial (Practice Facilitation (PF))

Not yet recruiting

Hypertension (HTN)

Practice Facilitation (PF)

(no location specified)

Jun 21, 2022